Paper7936902
Pulmonary hemorrhage risk in infants with a clinically diagnosed patent ductus arteriosus: a retrospective cohort study.
Garland J and 2 others. Pediatrics, 1994. Cited by 70 papers, by iCite.
Cite this record
ConductScience Library. Pulmonary hemorrhage risk in infants with a clinically diagnosed patent ductus arteriosus: a retrospective cohort study. Papers, record 7936902. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7936902
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pulmonary hemorrhage risk in infants with a clinically diagnosed patent ductus arteriosus: a retrospective cohort study.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ductus Arteriosus, Patent | Major topic |
| Hemorrhage | Major topic |
| Lung Diseases | Major topic |
| Phosphorylcholine | Major topic |
| Cohort Studies | |
| Drug Combinations | |
| Fatty Alcohols | |
| Female | |
| Humans | |
| Infant, Newborn | |
| Male | |
| Polyethylene Glycols | |
| Pulmonary Surfactants | |
| Respiratory Distress Syndrome, Newborn | |
| Retrospective Studies |
Source PubMed
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 70 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42650331 | PDA Treatment Strategy and Pulmonary Hemorrhage Risk in Very Low Birth Weight Infants: A Nationwide Cohort Study. | Children (Basel) | 2026 | https://conductscience.org/library/papers/42650331 | PubMed |
| 41634721 | Risk factors for pulmonary hemorrhage of very low birth weight infants: a meta-analysis. | Ital J Pediatr | 2026 | https://conductscience.org/library/papers/41634721 | PubMed |
| 41580570 | Predicting pulmonary hemorrhage in very low birth weight infants. | Pediatr Res | 2026 | https://conductscience.org/library/papers/41580570 | PubMed |
| 40829654 | Clinical Impact of the PDA and Its Management on Outcomes of Preterm Infants with NEC: A Review. | Am J Perinatol | 2026 | https://conductscience.org/library/papers/40829654 | PubMed |
| 40457234 | Characteristics of neonatal necrotizing enterocolitis in relation to the presence or absence of patent ductus arteriosus. | BMC Pregnancy Childbirth | 2025 | https://conductscience.org/library/papers/40457234 | PubMed |
| 40402206 | Agreement Between 2D and 3D Echocardiography in Measuring Dimensions of the Patent Ductus Arteriosus in Infants. | Pediatr Cardiol | 2026 | https://conductscience.org/library/papers/40402206 | PubMed |
| 38929201 | Intubation at Birth Is Associated with Death after Pulmonary Hemorrhage in Very Low Birth Weight Infants. | Children (Basel) | 2024 | https://conductscience.org/library/papers/38929201 | PubMed |
| 38487471 | Contemporary fluid management, humidity, and patent ductus arteriosus management strategy for premature infants among 336 hospitals in Asia. | Front Pediatr | 2024 | https://conductscience.org/library/papers/38487471 | PubMed |
| 38381375 | Post-ligation cardiac syndrome after surgical versus transcatheter closure of patent ductus arteriosus in low body weight premature infants: a multicenter retrospective cohort study. | Eur J Pediatr | 2024 | https://conductscience.org/library/papers/38381375 | PubMed |
| 37204599 | Increasing the dose of ibuprofen with postnatal age to close a hemodynamically significant patent ductus arteriosus in very preterm infants. | Eur J Pediatr | 2023 | https://conductscience.org/library/papers/37204599 | PubMed |
| 36330371 | Ultra-slim flexible bronchoscopy-guided topical hemostatic drugs administration for the management of life-threatening refractory pulmonary hemorrhage in a preterm infant: Case report. | Front Pediatr | 2022 | https://conductscience.org/library/papers/36330371 | PubMed |
| 36305112 | [Pulmonary hemorrhage in very low birth weight infants: risk factors and clinical outcome]. | Zhongguo Dang Dai Er Ke Za Zhi | 2022 | https://conductscience.org/library/papers/36305112 | PubMed |
| 36074378 | Percutaneous Closure of Ductus Arteriosus in Preterm Babies: The Initial Brazilian Experience. | Arq Bras Cardiol | 2022 | https://conductscience.org/library/papers/36074378 | PubMed |
| 35690691 | Hemodynamic consequences of respiratory interventions in preterm infants. | J Perinatol | 2022 | https://conductscience.org/library/papers/35690691 | PubMed |
| 34660481 | Decreased Incidence of Intraventricular Hemorrhage in Extremely Low Birth Weight Infants Using Customized Circulatory Management to Evaluate the Hemodynamic Change of Patent Ductus Arteriosus. | Front Pediatr | 2021 | https://conductscience.org/library/papers/34660481 | PubMed |
| 34189090 | Exploring prediction model and survival strategies for pulmonary hemorrhage in premature infants: a single-center, retrospective study. | Transl Pediatr | 2021 | https://conductscience.org/library/papers/34189090 | PubMed |
| 33072674 | Transcatheter Closure of Patent Ductus Arteriosus in Infants With Weight Under 1,500 Grams. | Front Pediatr | 2020 | https://conductscience.org/library/papers/33072674 | PubMed |
| 32524206 | Assessing Patent Ductus Arteriosus (PDA) Significance on Cardiac Output by Whole-Body Bio-impedance. | Pediatr Cardiol | 2020 | https://conductscience.org/library/papers/32524206 | PubMed |
| 31578421 | Comparison of 'post-patent ductus arteriosus ligation syndrome' in premature infants after surgical ligation vs. percutaneous closure. | J Perinatol | 2020 | https://conductscience.org/library/papers/31578421 | PubMed |
| 31486736 | CYP2C9*2 is associated with indomethacin treatment failure for patent ductus arteriosus. | Pharmacogenomics | 2019 | https://conductscience.org/library/papers/31486736 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7936902
GET https://conductscience.org/api/papers/v1/7936902/cited_by?page=2